|
CNBC'S MOST SHARED
- Unemployed? Bored? Make Money Playing Beer Pong
- Social Networking's 'Naked' Truth
- WPP's Sir Martin Sorrell on the Ad Recession
- The Highest Grossing (Inflation Adjusted) Movies of All Time
- Merrill's McCann Seen as UBS Wealth Frontrunner
- Geek Squad V. Gizmodo
- Warren Buffett's Top Three Investment Rules for the Average American
- Why You Should Watch Fund Flows
- Earnings 101: Beyond The Big Names
- Blog You!!!
- Stimulus Will Kick in Later this Year: President Obama
- Lender CIT Group Hires Premier Bankruptcy Adviser
- Government Selling Bank Stakes for Too Cheap: Panel
- Buffett's Top 3 Investment Rules for Average Americans
- Market Insider: Earnings Loom in the Week Ahead
- Bulls Get Summertime Blues, But It's Hot Fun for Bears
- As Banks Fail, Strong Institutions Become More Visible
- GM IPO in Second Quarter 2010 at the Earliest: CFO

- Merrill's McCann Seen as UBS Wealth Frontrunner
- Eric Schmidt on Government Scrutiny and Economic Recovery
- Market 360: The Week's Best & Worst
- Geek Squad V. Gizmodo
- Brandt: Google Chrome OS in the Post-PC Age
- Other People Are Weirder Than We Are
- Bank Failures: Is The Nightmare Over? (Video)
- California Here I Go? No.
- Roginsky: No More Mr. Nice Guy
- Commercial Conundrum
Merck filed last month for approval from the Food and Drug Administration for the use of its drug Gardasil by males between the ages 9 to 26, CNBC has confirmed.
Since 2006, Gardasil has been approved as a means of preventing cervical and other types of cancer in girls and women. Males carry and transmit the sexually-transmitted virus HPV, which is the leading cause of cervical cancer.
Gardasil, a vaccine against HPV, has been a blockbuster product for Merck [MRK
Loading...
()
], but sales growth for the drug has slowed. Approval for boys and older women could help reinvigorate that.
Merck is also awaiting for approval of use of the drug by older women.
GlaxoSmithKline [GSK
Loading...
()
] is currently developing a rival vaccine.









